Lack of prostate cancer radiosensitization by androgen deprivation

This publication has 11 references indexed in Scilit:

• Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation
  International Journal of Radiation Oncology*Biology*Physics, 2000
• The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions
  International Journal of Radiation Oncology*Biology*Physics, 2000
• After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
  Urological Research, 1999
• COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDY
  Journal of Urology, 1998
• Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation
  Cancer, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Androgen deprivation and radiation therapy: Sequencing studies using the shionogi in vivo tumor system
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial
  British Journal of Urology, 1997
• 97 A randomized trial comparing local tumor control following irradiation alone versus combined androgen withdrawal and irradiation in an androgen sensitive prostate cancer xenograft
  International Journal of Radiation Oncology*Biology*Physics, 1995